Clicky

Absci Corporation(ABSI)

Description: Absci Corporation, an AI-powered synthetic biology company, offers biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. The company was founded in 2011 and is headquartered in Vancouver, Washington.


Keywords: Biotechnology Biopharmaceutical Life Sciences Artificial Intelligence Pharmacy Drug Discovery Synthetic Biology Wuxi Biologics Genscript Biotech

Home Page: www.absci.com

ABSI Technical Analysis

18105 SE Mill Plain Boulevard
Vancouver, WA 98683
United States
Phone: 360 949 1041


Officers

Name Title
Mr. Sean McClain Founder, CEO, Pres & Director
Dr. Sarah Korman J.D., Ph.D. Chief Legal Officer & Corp. Sec.
Mr. Gregory T. Schiffman CPA, CPA, MBA Chief Financial Officer
Todd Bedrick CPA Sr. VP & Chief Accounting Officer
Mr. Jack Gold Chief Marketing Officer
Melissa Patterson Ph.D. Chief of Staff
Ms. Denise Dettore Chief People Officer
Dr. Andreas Busch Ph.D. Chief Innovation Officer
Jonathan Eads M.S. Sr. VP of Informatics
Thomas Wrona J.D., Ph.D. Sr. VP of Intellectual Property

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.8264
Price-to-Sales TTM: 42.7421
IPO Date: 2021-07-22
Fiscal Year End: December
Full Time Employees: 211
Back to stocks